Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy.
Chinese herbs nephropathy (CHN), a unique type of nephropathy has been associated with the intake of weight-reducing pills containing the Chinese herb Aristolochia fangchi. Moreover, an association between the use of A. fangchi and urothelial cancer in CHN patients has been reported indicating that aristolochic acid (AA) the major alkaloid of A. fangchi might be the causal agent. Similarities of CHN to the Balkan endemic nephropathy (BEN) have led to the hypothesis of a common etiological agent for both diseases. Evidence has accumulated that BEN is an environmentally-induced disease strongly associated with the fungal mycotoxin ochratoxin A (OTA). Both, AA and OTA are nephrotoxic and carcinogenic and induce the formation of DNA adducts. As OTA has been suspected as fungal contaminant in the herbal batches used for the preparation of the weight-reducing pills we analysed tissues from CHN patients by the 32P-postlabeling procedure for the presence of DNA adducts related to both OTA and AA exposure. Whereas, AA-specific DNA adducts were detected in all five urinary tract tissues from five patients (total RAL: 32-251 adducts per 10(9) nucleotides), OTA-related DNA adducts were detectable in two kidneys and one ureter only (total RAL: 1.5-3.7 adducts per 10(9) nucleotides). Thus, OTA-related DNA adduct levels were about 50 times lower than AA-DNA adduct levels. In female and male rats that were treated with the slimming regimen in the same way like the CHN patients except that the amount of Chinese herbs was 10 times higher, AA-DNA adducts were found in kidney tissues (total RAL ranging from 51 to 83 adducts per 10(9) nucleotides) but adducts derived from OTA were not observed. These results demonstrate that OTA-related DNA adducts do not play a key role in CHN or CHN-associated urothelial cancer.
Arlt
V M
VM
Division of Molecular Toxicology, German Cancer Research Centre, Im Neuenheimer Feld 280, D-69120, Heidelberg, Germany. v.arlt@icr.ac.uk
Pfohl-Leszkowicz
A
A
Cosyns
J
J
Schmeiser
H H
HH
D000328:Adult; D000818:Animals; D019440:Anti-Obesity Agents / Q000009:adverse effects*; D034341:Aristolochic Acids; D001449:Balkan Nephropathy / Q000209:etiology; D001530:Belgium / Q000453:epidemiology; D018736:DNA Adducts / Q000032:analysis*; D004365:Drugs, Chinese Herbal / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009183:Mycotoxins / Q000633:toxicity; D009793:Ochratoxins / Q000633:toxicity*; D010616:Phenanthrenes / Q000633:toxicity*; D051381:Rats; D017208:Rats, Wistar; D051437:Renal Insufficiency / Q000139:chemically induced* / Q000453:epidemiology / Q000209:etiology
D019440:Anti-Obesity Agents; D034341:Aristolochic Acids; D018736:DNA Adducts; D004365:Drugs, Chinese Herbal; D009183:Mycotoxins; D009793:Ochratoxins; D010616:Phenanthrenes; C025589:ochratoxin A; C000228:aristolochic acid I